Prenatal diagnosis of junctional epidermolysis buliosa associated with pyloric atresia was carried out in a couple at risk. Their two previous children had died during the first months of life of the same disorder despite surgery for the pyloric abnormality. Ultrastructural study of fetal skin biopsies obtained at 18 weeks' gestation showed dermal-epidermal separation at the lamina lucida level, while ultrasound showed marked stomach dilatation. Light microscopy of pyloric tissue obtained after termination showed the pyloric lumen to be replaced by loose connective tissue with no inflammatory reaction. Immunofluorescence studies on the skin specimens with the monoclonal antibody GB3, known to be absent in 'lethal' junctional epidermolysis buliosa skin, disclosed a marked positivity suggesting that the junctional epidermolysis buliosa in this case may be of the 'non-lethal' type.
We now report the first prenatal diagnosis of epidermolysis bullosa associated with pyloric atresia performed by ultrastructural examination of fetal skin biopsies in a couple at risk, whose previous son and daughter had died of the same combined disorder.
Case report A 25 year old woman, gravida 4, para 3, was referred for prenatal diagnosis of epidermolysis bullosa (EB) associated with pyloric atresia (PA).
Her first pregnancy ended with the delivery at 34 weeks' gestation of a 2150 g girl affected with EB and PA. No polyhydramnios was recorded. Pyloroplasty was performed but the infant died at 4 days of age. No necropsy or skin biopsy were performed.
In the next pregnancy she delivered an unaffected newborn. She later had a pregnancy complicated by polyhydramnios which ended with the delivery at 38 weeks' gestation of a 3000 g boy affected with EB and PA. Gastroduodenostomy was performed and light microscopy of sections of the pylorus showed that the lumen was obliterated by loose connective tissue. Skin electron microscopy showed a cleavage at the lamina lucida level, between basal keratinocytes and lamina densa. The infant died of sepsis at 3 months of age and there was no necropsy.
No other family members had a history of congenital abnormalities or skin disease and the parents were not related.
Prenatal diagnosis was requested by the parents in a subsequent pregnancy.
Methods
Fetal skin biopsies were obtained at 18 weeks' gestation by transabdominal, ultrasound guided fetal skin biopsy. 21G biopsy forceps were used, introduced into the amniotic cavity through a 18G needle. Five specimens were taken from the fetal trunk and scalp. For (fig 3) . Electron microscopy performed on specimens obtained from trachea, oesophagus, stomach, and duodenum showed rare and atrophic hemidesmosome-like structures but no junctional mucosal separation (fig 4) . Ultrastructural controls of skin samples taken from the back, limbs, and scalp confirmed the findings observed prenatally.
Immunofluorescence mapping studies were performed in skin specimens with antibodies against bullous pemphigoid, laminin, and type IV collagen. Bullous pemphigoid was found at the roof of the cleavage (fig 5, left) , while laminin and type IV collagen were found at the base (fig 5, centre) , consistent with a split within the lamina lucida. In addition, a new monoclonal antibody (GB3), which has previously been shown to be absent in 'lethal' junctional EB, was tested. In our specimens, GB3 was markedly positive on the skin obtained from the trunk and thigh (fig 5 , right) without significant differences from specimens obtained from the same areas from age matched controls. GB3 staining was also positive Figure 5 Immunofluorescence micrographs ofskin specimens obtained from the aborted fetus. Bullous pemphigoid serum stained the roofofthe blister (left), monoclonal antibody anti-type IV collagen stained the base ofthe blister (centre), and the monoclonal antibody GB3 showed intense labelling of the epidermal basal membrane, both at the bottom and top ofthe blister cavity (right). = blister cavity. Prenatal diagnosis ofjunctional epidermolysis bullosa associated with pyloric atresia Figure 6 Immunofluorescence micrographs ofstomach specimens obtainedfrom the abortedfetus andfrom a normal age matched fetus. No labelling ofthe specimensfrom the abortedfetus (left) orfrom the normalfetus (centre) was seen with the monoclonal antibody GB3. Note, in comparison, normal staining ofthe same specimen from the normalfetus with anti-type IV collagen monoclonal antibody (right).
on gastrointestinal mucosa, except the stomach and pylorus ( fig 6) .
Discussion
Epidermolysis bullosa represents a heterogeneous family of hereditary mechanobullous diseases in which minimal trauma results in blister formation. EB is classified into three major groups according to the ultrastructural level of cleavage: simplex (epidermolytic), junctional, and dystrophic (dermolytic). Junctional EB is characterised by a cleavage through the lamina lucida of the epidermal basal membrane and is composed of at least two distinct clinical subtypes, one in which patients die in the first months of life, known as 'lethal' junctional EB or Herlitz's disease, and another in which patients are able to survive into adulthood, known as 'non-lethal' junctional EB or generalised atrophic benign EB.4 Both types present the same ultrastructural findings, are inherited as an autosomal recessive trait, and are clinically characterised by blisters that heal with atrophy but with no milia or scarring.
In our case and in the majority of recently reported cases, the EB associated with pyloric atresia has been ultrastructurally shown to be of the junctional type. 1-3 The electron microscopic study performed both in one of the previous affected patients and in the fetal skin specimens disclosed a cleavage in the plane of the lamina lucida with hypoplasia of hemidesmosomes and atrophic sub-basal dense plates.
Pyloric atresia is a rare congenital anomaly representing about 1% of all gastrointestinal tract atresia. It is transmitted as an autosomal recessive trait and can result from a failure of the tube to canalise during development or a mechanical or vascular injury to the previously normal fetal intestine.5
Some authors have proposed that the pyloric obstruction in this syndrome results from intrauterine mucosal damage within junctional EB with subsequent peptic digestion and inflammatory scarring reaction.6 Our findings do not agree with this hypothesis. Histological study of the obliterated pyloric lumen at 18 weeks' gestation showed only mucoid or loose connective tissue with no inflammatory reaction.
Another, more likely, hypothesis is that this association results from the action of two closely linked genes or from the pleiotropic expression of a single abnormal gene. This is supported by the fact that no segregation of the two traits was observed in our family nor in the other six families reported so far.' 2 Autosomal recessive inheritance is suggested by the occurrence of this disorder in opposite sex sibs in our case and in previous reports' 2 and in children born to consanguineous parents in previous reports. 2 The fatal outcome frequently observed in this syndrome could result from the EB alone or from the combination of EB and pyloric atresia. Pyloric atresia without EB carries a good long term prognosis with early operative management. In contrast, most of the infants affected with pyloric atresia and EB died despite early surgical intervention on the pylorus. In these cases the EB was nearly always 'lethal' or Herlitz type even though the fatal outcome could have resulted from a 'non-lethal' EB complicating the postoperative management of the gastrointestinal abnormality.
Ultrastructural study of fetal skin biopsies obtained at 18 weeks' gestation by fetoscopy or under direct echographic control is now a well established method for prenatal diagnosis of EB.7 As shown by the present study, in the association of EB with pyloric atresia careful ultrasound study of the stomach may suggest the diagnosis, which must be confirmed by ultrastructural study of fetal skin biopsy. Recently a new monoclonal antibody (GB3) that recognises an antigen(s) within the lamina lucida has been reported not to be expressed or poorly expressed in 'lethal' junctional EB skin and has been used in confirming the prenatal diagnosis of this disease.8 9 In our case we observed a strong positivity of GB3 at the dermalgroup.bmj.com on November 6, 2017 -Published by http://jmg.bmj.com/ Downloaded from epidermal junction at 18 weeks of gestation. This may indicate that the junctional EB was of the 'non-lethal' type. However, the interpretation of this finding awaits further studies on the antigenic composition of the epidermal basal membrane zone. At present, electron microscopy seems to be the only reliable method of prenatal diagnosis of this disease.
